Page last updated: 2024-08-22

camptothecin and 15-deoxy-delta(12,14)-prostaglandin j2

camptothecin has been researched along with 15-deoxy-delta(12,14)-prostaglandin j2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujita, M; Koma, H; Nakamura, T; Okamura, N; Yagami, T; Yamamori, M; Yamamoto, Y	1

Other Studies

1 other study(ies) available for camptothecin and 15-deoxy-delta(12,14)-prostaglandin j2

Article	Year
15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways. Biochemical and biophysical research communications, 2011, Jul-08, Volume: 410, Issue:3 Topics: Anilides; Antineoplastic Agents; Apoptosis; Camptothecin; Carcinoma, Renal Cell; Caspase 3; Cell Line, Tumor; DNA Topoisomerases, Type II; Drug Synergism; Enzyme Activation; Humans; Kidney Neoplasms; PPAR gamma; Prostaglandin D2	2011

Article

Year

15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways.

Biochemical and biophysical research communications, 2011, Jul-08, Volume: 410, Issue:3

Topics: Anilides; Antineoplastic Agents; Apoptosis; Camptothecin; Carcinoma, Renal Cell; Caspase 3; Cell Line, Tumor; DNA Topoisomerases, Type II; Drug Synergism; Enzyme Activation; Humans; Kidney Neoplasms; PPAR gamma; Prostaglandin D2

2011